Primary liver tumors such as hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA)
Conditions
Interventions
Low-grade HCC group vs. High-grade HCC group:None
Sponsors
Zhejiang Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age >= 18 years; 2. Patients with a clinical or pathological diagnosis, or those judged to have suspected primary liver tumors (such as hepatocellular carcinoma or cholangiocarcinoma or liver metastases; 3. Voluntary participation in the study and provision of signed informed consent.
Exclusion criteria
Exclusion criteria: 1.For Patients with Primary Liver Tumors: (1) Lack of pathological confirmation;(2) Prior receipt of any local or systemic therapy for the tumor; (3) Poor-quality MRE images due to factors such as iron deposition or motion artifacts; (4) Presence of severe hepatic insufficiency (Child-Pugh Class C) or other contraindications. 2.Patients with Liver Metastases: (1) Unknown primary origin of the metastasis; (2) Previous local treatment specifically targeting the liver metastases; (3) Poor-quality MRE images.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MRE elasticity,viscosity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-Free Survival (PFS);Overall Survival (OS);Changes in liver injury indicators; | — |
Countries
China
Contacts
Public ContactYihuan Wang
Zhejiang Cancer Hospital
Outcome results
None listed